Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bioptix Inc (BIOP)

Bioptix Inc (BIOP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Bioptix, Inc. is an analytical instrumentation company, develops an array-based bio molecule detection systems and molecular interaction analysis instruments. The company's products pipeline includes cell array biodetector systems, and biochip and optical cartridges; and pre-production small footprint and single cell biodetector systems. It serves clinical biomarkers and diagnostics, personalized medicine, infectious disease, drug discovery, biopharma and low molecular drug development, pharmaceutical research, biological warfare agents, academic research, environmental monitoring, kinetic analyses, forensics, antibody development and quality control and process analysis industries. Bioptix, Inc., formerly known as Venaxis Inc., is based in Boulder, Colorado.
(Values in U.S. Thousands) Dec, 2016 Dec, 2015 Dec, 2014 Dec, 2013 Dec, 2012
Sales 100 190 260 140 60
Sales Growth -47.37% -26.92% +85.71% +133.34% -78.57%
Net Income -4,270 -8,750 -10,440 -12,140 -9,210
Net Income Growth +51.20% +16.19% +14.00% -31.81% +9.79%
(Values in U.S. Thousands) Dec, 2016 Dec, 2015 Dec, 2014 Dec, 2013 Dec, 2012
Total Assets 17,040 20,860 28,720 18,630 16,610
Total Assets Growth -18.31% -27.37% +54.16% +12.16% +90.48%
Total Liabilities 2,120 4,790 5,030 5,690 5,920
Total Liabilities Growth -55.74% -4.77% -11.60% -3.89% +20.82%
(Values in U.S. Thousands) Dec, 2016 Dec, 2015 Dec, 2014 Dec, 2013 Dec, 2012
Operating Cash Flow -5,510 -6,860 -9,200 -9,720 -5,480
Operating Cash Flow Growth +19.68% +25.43% +5.35% -77.37% +34.21%
Net Cash Flow 3,510 -1,520 -2,110 -5,310 8,000
Change in Net Cash Flow +330.92% +27.96% +60.26% -166.38% +234.91%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar